Objective: In Multiple Sclerosis (MS), non-adherence is related to suboptimal response to treatment, including disease relapses and the need for more expensive healthcare. The aim of this study was to identify predictors related to treatment adherence drugs in Iranian MS patients.
No takes yet. Share an insight, caveat, or question.
Hamtaeigashti et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: